@dansfera: Big risks, bigger rewards—or total disaster? This investor breaks down the high-stakes reality of betting on small biopharma stocks. While working for a company like Iovans Biotherapeutics was a massive gamble back when it was under a $1 billion market cap, the payoff for those who took the leap has been life-changing. It’s a powerful reminder that growth often comes with volatility, and sometimes the safest jobs are the ones that have already proven they can survive the storm. #biotech #investing #careergrowth #biopharma #riskmanagement